Novel Coronavirus: What Neuroradiologists as Citizens of the World Need to Know

References

1. 1.↵
   1. Huang C,
   2. Wang Y,
   3. Li X, et al

   . Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020;395:497–506 doi:10.1016/S0140-6736(20)30183-5 pmid:31986264

   CrossRefPubMed
2. 2.↵
   Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19). February 16-24, 2020. https://www.who.int/docs/default-source/coronaviruse/who-china-joint-mission-on-covid-19-final-report.pdf. Accessed March 12, 2020
3. 3.↵
   1. Zhou P,
   2. Yang XL,
   3. Wang XG, et al

   . A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 2020;579:270–73 doi:10.1038/s41586-020-2012-7 pmid:32015507

   CrossRefPubMed
4. 4.↵
   1. Chen J

   . Pathogenicity and transmissibility of 2019-nCoV:a quick overview and comparison with other emerging viruses. Microbes Infect 2020 Feb 4. [Epub ahead of print] doi:10.1016/j.micinf.2020.01.004

   CrossRef
5. 5.↵
   1. Zhang H,
   2. Penninger JM,
   3. Li Y, et al

   . Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target. Intensive Care Med 2020 Mar 3. [Epub ahead of print] doi:10.1007/s00134-020-05985-9 pmid:32125455

   CrossRefPubMed
6. 6.↵
   1. Du L,
   2. He Y,
   3. Zhou Y, et al

   . The spike protein of SARS-CoV: a target for vaccine and therapeutic development. Nat Rev Microbiol 2009;7:226–36 doi:10.1038/nrmicro2090 pmid:19198616

   CrossRefPubMed
7. 7.↵
   1. Tian X,
   2. Li C,
   3. Huang A, et al

   . Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody. Emerg Microbes Infect 2020;9:382–85 doi:10.1080/22221751.2020.1729069 pmid:32065055

   CrossRefPubMed
8. 8.↵
   1. Rothe C,
   2. Schunk M,
   3. Sothmann P, et al

   . Transmission of 2019-nCoV infection from an asymptomatic contact in Germany. N Engl J Med 2020;382:970–71 doi:10.1056/NEJMc2001468 pmid:32003551

   CrossRefPubMed
9. 9.↵
   1. Bai Y,
   2. Yao L,
   3. Wei T, et al

   . Presumed asymptomatic carrier transmission of COVID-19. JAMA 2020 Feb 21. [Epub ahead of print] doi:10.1001/jama.2020.2565 pmid:32083643

   CrossRefPubMed
10. 10.↵
    1. Guan WJ,
    2. Ni ZY,
    3. Hu Y, et al

    . Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 2020 Feb 28. [Epub ahead of print] doi:10.1056/NEJMoa2002032 pmid:32109013

    CrossRefPubMed
11. 11.↵
    1. Chen N,
    2. Zhou M,
    3. Dong X, et al

    . Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 2020;395:507–13 doi:10.1016/S0140-6736(20)30211-7 pmid:32007143

    CrossRefPubMed
12. 12.↵
    1. Ai T,
    2. Yang Z,
    3. Hou H, et al

    . Correlation of chest CT and RT-PCR testing in coronavirus disease 2019 (COVID-19) in China: a report of 1014 cases. Radiology 2020 Feb 26. [Epub ahead of print] doi:10.1148/radiol.2020200642 [pmid:32101510

    CrossRefPubMed
13. 13.↵
    1. Kanne JP,
    2. Little BP,
    3. Chung JH, et al

    . Essentials for radiologists on COVID-19: An Update—Radiology Scientific Expert Panel. Radiology 2020 Feb 27. [Epub ahead of print] doi:10.1148/radiol.2020200527 pmid:32105562

    CrossRefPubMed
14. 14.↵
    1. Jin YH,
    2. Cai L,
    3. Cheng ZS, et al

    ; Zhongnan Hospital of Wuhan University Novel Coronavirus Management and Research Team, Evidence-Based Medicine Chapter of China International Exchange and Promotive Association for Medical and Health Care (CPAM), A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version). Mil Med Res 2020;7:4 doi:10.1186/s40779-020-0233-6 pmid:32029004

    CrossRefPubMed
15. 15.↵
    1. Yang W,
    2. Yan F

    . Patients with RT-PCR confirmed COVID-19 and normal chest CT. Radiology 2020 Mar 6. [Epub ahead of print] doi:10.1148/radiol.2020200702 pmid:32142398

    CrossRefPubMed
16. 16.↵
    ACR recommendations for the use of chest radiography and computed tomography (CT) for suspected COVID-19 infection. March 11, 2020.https://www.acr.org/Advocacy-and-Economics/ACR-Position-Statements/Recommendations-for-Chest-Radiography-and-CT-for-Suspected-COVID19-Infection. Accessed March 12, 2020
17. 17.↵
    1. Stempniak M

    . CT should not be used as first-line tool against coronavirus, ACR warns following pandemic declaration. Radiology Business. March 11, 2020. https://www.radiologybusiness.com/topics/care-delivery/ct-scan-coronavirus-chest-x-ray-radiology-covid-19. Accessed March 12, 2020
18. 18.↵
    1. Wang M,
    2. Cao R,
    3. Zhang L, et al

    . Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res 2020;30:269–71 doi:10.1038/s41422-020-0282-0 pmid:32020029

    CrossRefPubMed
19. 19.↵
    1. Gordon CJ,
    2. Tchesnokov EP,
    3. Feng JY, et al

    . The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from Middle East respiratory syndrome coronavirus. J Biol Chem 2020 Feb 24. [Epub ahead of print] doi:10.1074/jbc.AC120.013056] pmid:32094225

    CrossRefPubMed
20. 20.↵
    1. Gao J,
    2. Tian Z,
    3. Yang X

    . Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies. Biosci Trends 2020 Feb 19. [Epub ahead of print] doi:10.5582/bst.2020.01047 pmid:32074550

    CrossRefPubMed
21. 21.↵
    1. Lu H

    . Drug treatment options for the 2019-new coronavirus (2019-nCoV). Biosci Trends 2020 Jan 28. [Epub ahead of print] doi:10.5582/bst.2020.01020 pmid:31996494

    CrossRefPubMed
22. 22.↵
    1. Wrapp D,
    2. Wang N,
    3. Corbett KS, et al

    . Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science 2020;367:1260–63 doi:10.1126/science.abb2507 pmid:32075877

    Abstract/FREE Full Text
23. 23.↵
    1. Seto WH,
    2. Tsang D,
    3. Yung RW, et al

    ; Advisors of Expert SARS group of Hospital Authority. Effectiveness of precautions against droplets and contact in prevention of nosocomial transmission of severe acute respiratory syndrome (SARS). Lancet 2003;361:1519–20 doi:10.1016/s0140-6736(03)13168-6 pmid:12737864

    CrossRefPubMedWeb of Science
24. 24.↵
    1. Kooraki S,
    2. Hosseiny M,
    3. Myers L, et al

    . Coronavirus (COVID-19) outbreak: what the department of radiology should know. J Am Coll Radiol 2020 Feb 19. [Epub ahead of print] doi:10.1016/j.jacr.2020.02.008 pmid:32092296

    CrossRefPubMed
25. 25.↵
    1. Kampf G,
    2. Todt D,
    3. Pfaender S, et al

    . Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents. J Hosp Infect 2020;104:246–51 doi:10.1016/j.jhin.2020.01.022 pmid:32035997

    CrossRefPubMed
26. 26.↵
    1. Anderson RM,
    2. Heesterbeek H,
    3. Klinkenberg D, et al

    . How will country-based mitigation measures influence the course of the COVID-19 epidemic? Lancet 2020 March 6. [Epub ahead of print] doi:10.1016/S0140-6736(20)30567-5 pmid:32164834

    CrossRefPubMed
27. 27.↵
    World Health Organization. Coronavirus Disease 2019 (COVID-19) Situation Report—44. March 4, 2020.https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200304-sitrep-44-covid-19.pdf?sfvrsn=93937f92_6. Accessed March12, 2020